CD19 and B-cell chronic lymphocytic leukemia: As demonstrated by Wong et al., the formation of immunological synapses between T cells and CLL cells induced in vitro by blinatumomab indicates that this CD19/CD3 BiTE is able to overcome the T-cell dysfunction frequently observed in CLL patients (234).